GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citius Oncology Inc (NAS:CTOR) » Definitions » Issuance of Debt

CTOR (Citius Oncology) Issuance of Debt : $3.80 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Citius Oncology Issuance of Debt?

Citius Oncology's Issuance of Debt for the six months ended in Sep. 2024 was $3.80 Mil.

Citius Oncology's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was $3.80 Mil.

Citius Oncology Issuance of Debt Historical Data

The historical data trend for Citius Oncology's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citius Oncology Issuance of Debt Chart

Citius Oncology Annual Data
Trend Sep22 Sep23 Sep24
Issuance of Debt
- - 3.80

Citius Oncology Semi-Annual Data
Sep22 Sep23 Sep24
Issuance of Debt - - 3.80

Citius Oncology Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was $3.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Citius Oncology Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Citius Oncology's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Citius Oncology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citius Oncology Inc (NAS:CTOR) » Definitions » Issuance of Debt
Comparable Companies
INCR ASRT CPIX DERM RGC OPTN RMTI MRMD ETST SCYX ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
N/A
Address
11 Commerce Drive, First Floor, Cranford, NY, USA, 07016
Website
https://www.citiusonc.com
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.